Material-Methods
After ethical committee approval and permission being granted by the
Republic of Turkey Ministry of Health, the data of COVID-19 patients who
were hospitalized between 15 May and 15 June 2020 at a tertiary center
were collected retrospectively. The patients who were <18
years old, had any type of chronic medical illness, or any type of
urinary cancers or history of urological operations were excluded from
the study. The remaining patients were contacted and asked if they
wanted to participate in the study. All of the patients agreed to
participate and complete the questionnaires.
All patients answered socio-demographic form questions. Then the Male
patients then replied to the questions of the International Prostate
Symptom Score (IPSS), and female patients responded to the questions of
the Urinary Symptom Profile (USP). Both male and female patients
responded to these questions three times, based on their condition
pre-COVID-19, during hospitalization, and post-hospitalized time. LUTS
can be evaluated with a total IPSS score, and with this score system
voiding and storage symptoms can be detected separately (10-19). USP,
which was designed by Haab et al (11-8), and translated in Turkish by
Bilge and Beji(11), has been used for both men and women who have stress
incontinence, an overactive bladder, and/or obstructive symptoms.
The SPSS 21.0 program was used in the statistical analysis of the data.
The variables were expressed as mean ± standard deviation (X ± SD), and
the percent (%) value was calculated for variables determined by the
count. The “p” significance value was taken as 0.05 in all the
statistical analyses.